EVOLVE-BDT: TBCRC Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
University of North Carolina at Chapel Hill (breast cancer): The team will develop an evolutionary trial for breast cancer patients using new statistical approaches that maximize the likelihood of treatment success for each individual patient using biomarker-driven therapies.